IP Verse

Amorphous Lercanidipine Hydrochloride

PatentPatent Analysis

EP1856051

RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA
Application Number
EP06723128A
Filing Date
Feb 24, 2006
Status
Revoked
Oct 14, 2022
Grant Date
Nov 13, 2019
External Links
Slate, Register, Google Patents

Bibliography

The patent EP1856051B1 was granted to Recordati Industria Chimica E Farmaceutica on Nov 13, 2019 following the initial filing on Feb 24, 2006 under the application number EP06723128A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

STADA ARZNEIMITTELAug 12, 2020ADMISSIBLE
HEUMANN PHARMA GENERICAAug 4, 2020ADMISSIBLE
LEDERER & KELLER PATENTANWALTE PARTNERSCHAFT MBBJul 8, 2020ADMISSIBLE
FRESENIUS KABI DEUTSCHLANDJul 1, 2020ADMISSIBLE
SANDOZJun 8, 2020ADMISSIBLE
ELKINGTON AND FIFEApr 6, 2020ADMISSIBLE
GLENMARK LIFE SCIENCESNov 13, 2019ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents